- Home
- NEE vs ABBV Comparison
NEE vs ABBV Comparison
Compare NEE & ABBV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NEE | ABBV |
|---|---|---|
| Founded | 1925 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 193.1B | 400.9B |
| IPO Year | N/A | 2012 |
Fundamental Metrics
Financial Performance| Metric | NEE | ABBV |
|---|---|---|
| Price | $91.29 | $231.93 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 19 |
| Target Price | $92.38 | ★ $247.06 |
| AVG Volume (30 Days) | ★ 8.7M | 6.2M |
| Earning Date | 01-01-0001 | 04-13-2026 |
| Dividend Yield | 2.69% | ★ 2.93% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.36 |
| Revenue | N/A | ★ $61,160,000,000.00 |
| Revenue This Year | $14.41 | $11.90 |
| Revenue Next Year | $8.48 | $8.24 |
| P/E Ratio | ★ $27.64 | $100.14 |
| Revenue Growth | N/A | ★ 8.57 |
| 52 Week Low | $61.72 | $164.39 |
| 52 Week High | $95.91 | $244.81 |
Technical Indicators
Market Signals| Indicator | NEE | ABBV |
|---|---|---|
| Relative Strength Index (RSI) | 51.21 | 55.01 |
| Support Level | $79.76 | $220.11 |
| Resistance Level | $95.91 | $238.17 |
| Average True Range (ATR) | 2.31 | 5.39 |
| MACD | -0.48 | 0.66 |
| Stochastic Oscillator | 19.20 | 62.95 |
Price Performance
Historical ComparisonAbout NEE NextEra Energy Inc.
NextEra Energy's regulated utility, Florida Power & Light, is the largest rate-regulated utility in Florida. The utility distributes power to over 6 million customer accounts in Florida and owns 36 gigawatts of generation. FP&L contributes roughly 70% of NextEra's consolidated operating earnings. NextEra Energy Resources, the renewable energy segment, generates and sells power throughout the United States and Canada with nearly 40 GW of generation capacity, including natural gas, nuclear, wind, and solar.
About ABBV AbbVie Inc.
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.